🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this clinical trial is to ievaluate the effect of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-12
Trial ID
NCT06449625
Treatments Being Tested
This study will look at the change in participants' body weight from the st...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-01-21
Trial ID
NCT03811574
Treatments Being Tested
Epicardial adipose tissue (EAT) is the visceral fat of the heart. EAT could...
Status
Completed
Location
University of Miami
Start Date
2018-09-01
Trial ID
NCT03260881
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested
The purpose of this clinical study is to find out if NNC0487-0111 is safe a...
Status
Not Yet Recruiting
Location
Encore Medical Research LLC
Start Date
2026-05-20
Trial ID
NCT07400107
Treatments Being Tested
The current study has two aims: 1. to test the hypothesis that a single do...
Status
Unknown
Location
Tartu University Hospital
Start Date
2023-04-17
Trial ID
NCT05804513
Treatments Being Tested
The two main aims of this clinical study is; 1. To investigate if the resu...
Status
Withdrawn
Location
University hospital of Southern Denmark
Start Date
2025-04-01
Trial ID
NCT06619015
Treatments Being Tested
This randomized study evaluates the effect of subcutaneous semaglutide /in ...
Status
Terminated
Location
Geisinger Medical Center
Start Date
2021-07-23
Trial ID
NCT04741074
This study is being done to look at the efficacy and safety of NNC0487-0111...
Status
Recruiting
Location
Dignity Health, Mercy Gilbert
Start Date
2026-05-05
Trial ID
NCT07571109
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-05
Trial ID
NCT00688701
Treatments Being Tested